E Fund Management Co., Ltd. Aldeyra Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.93 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$6.11 - $8.16 $1,997 - $2,668
327 Added 2.4%
13,939 $93,000
Q2 2023

Aug 11, 2023
BUY
$7.11 - $11.89 $96,781 - $161,846
13,612 New
13,612 $114,000
Q1 2021

May 12, 2021
BUY
$6.53 - $14.42 $44,253 - $97,724
6,777 New
6,777 $80,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $283M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email